Cargando…
Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
BACKGROUND: The 2030 goal for schistosomiasis is elimination as a public health problem (EPHP), with mass drug administration (MDA) of praziquantel to school-age children (SAC) as a central pillar of the strategy. However, due to coronavirus disease 2019, many mass treatment campaigns for schistosom...
Autores principales: | Kura, Klodeta, Ayabina, Diepreye, Toor, Jaspreet, Hollingsworth, T Deirdre, Anderson, Roy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928593/ https://www.ncbi.nlm.nih.gov/pubmed/33515038 http://dx.doi.org/10.1093/trstmh/traa202 |
Ejemplares similares
-
Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
por: Ayabina, Diepreye, et al.
Publicado: (2021) -
Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
por: Kura, Klodeta, et al.
Publicado: (2022) -
SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
por: Graham, Matthew, et al.
Publicado: (2021) -
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020) -
Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)